FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia

NCT07283094 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Myelodysplastic Syndrome

Interventions

DRUG: Decitabine
DRUG: Venetoclax
DRUG: FHD-286

Sponsor

Montefiore Medical Center

Collaborators

[object Object]